Systematic review on Rocuronium continuous infusion for deep neuromuscular blockade

Detalhes bibliográficos
Autor(a) principal: Couto, Mafalda
Data de Publicação: 2021
Outros Autores: Couto, J. Guilherme, Nunes, Catarina S., Vide, Sérgio, Amorim, Pedro, Mendes, Joaquim
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.2/11412
Resumo: Background: Rocuronium is a muscle relaxant with increased use due to its binding relation with the reversal agent sugammadex. The purpose of this review entails the investigation of its use for the maintenance of Deep Neuromuscular Block (NMB) via continuous infusion. Methods: Based on PRISMA systematic search guidelines, databases included PubMed, ISI Web of Science, Cochrane Library and Google Scholar. This comprehensive search addresses surgical patients under deep muscle relaxation via continuous rocuronium infusion. The main indicators were the rocuronium administration, NMB monitoring approaches and effects in order to maintain the deep level of relaxation, as well as reversal time after a standard dose of sugammadex. Results: Despite the variance in approaches found in the literature, findings show the overall maintenance of deep NMB requires approximately 0.758 mg.kg-1h-1 of rocuronium (according to the PTC target of 0-10, 0-5 and 1-2, mean estimates are 0.445, 0.65 and 0.833 mg.kg-1h-1 respectively), suggesting that a lower range and a smaller maximum of PTC response require higher amount of rocuronium for its maintenance. The standard dose of sugammadex (4 mg/kg), administered at the end of the surgery takes longer [2.85 (1.17) min] than when they are administered after moderate NMB recovery [1.68 (0.47) min]. Conclusion: Continuous infusion for deep NMB presents inherent advantages in terms of maintenance and stability of muscle relaxation. Monitoring and rocuronium administration approaches are fundamental and intrinsically connected to provide a stable and improved maintenance of deep NMB.
id RCAP_c0299a77f09788543479e2e8e00e75f8
oai_identifier_str oai:repositorioaberto.uab.pt:10400.2/11412
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Systematic review on Rocuronium continuous infusion for deep neuromuscular blockadeRevisão sistemática da infusão contínua de Rocurônio para bloqueio neuromuscular profundoAnesthesiaNeuromuscular blockadePost-tetanic countContinuous infusionDeep NMBRocuroniumAnestesiaBloqueio neuromuscularContagem pós-tetânicaInfusão contínuaBNM profundoRocurônioBackground: Rocuronium is a muscle relaxant with increased use due to its binding relation with the reversal agent sugammadex. The purpose of this review entails the investigation of its use for the maintenance of Deep Neuromuscular Block (NMB) via continuous infusion. Methods: Based on PRISMA systematic search guidelines, databases included PubMed, ISI Web of Science, Cochrane Library and Google Scholar. This comprehensive search addresses surgical patients under deep muscle relaxation via continuous rocuronium infusion. The main indicators were the rocuronium administration, NMB monitoring approaches and effects in order to maintain the deep level of relaxation, as well as reversal time after a standard dose of sugammadex. Results: Despite the variance in approaches found in the literature, findings show the overall maintenance of deep NMB requires approximately 0.758 mg.kg-1h-1 of rocuronium (according to the PTC target of 0-10, 0-5 and 1-2, mean estimates are 0.445, 0.65 and 0.833 mg.kg-1h-1 respectively), suggesting that a lower range and a smaller maximum of PTC response require higher amount of rocuronium for its maintenance. The standard dose of sugammadex (4 mg/kg), administered at the end of the surgery takes longer [2.85 (1.17) min] than when they are administered after moderate NMB recovery [1.68 (0.47) min]. Conclusion: Continuous infusion for deep NMB presents inherent advantages in terms of maintenance and stability of muscle relaxation. Monitoring and rocuronium administration approaches are fundamental and intrinsically connected to provide a stable and improved maintenance of deep NMB.Introdução: Rocurônio é um relaxante muscular com uso aumentado devido à sua relação de ligação com o agente de reversão sugamadex. O objetivo desta revisão consiste na investigação de seu uso para a manutenção do Bloco Neuromuscular Profundo (BNM) por infusão contínua. Métodos: Com base nas diretrizes de busca sistemática do PRISMA, as bases de dados incluíram PubMed, ISI Web of Science, Cochrane Library e Google Scholar. Esta pesquisa abrangente aborda pacientes cirúrgicos sob relaxamento muscular profundo por meio de infusão contínua de rocurônio. Os principais indicadores foram a administração de rocurônio, as abordagens e efeitos de monitoramento do BNM para manter o nível de relaxamento profundo, bem como o tempo de reversão após uma dose padrão de sugamadex. Resultados: Apesar da variação nas abordagens encontradas na literatura, os achados mostram que a manutenção geral do BNM profundo requer aproximadamente 0,758 mg.kg -1 h -1 de rocurônio (de acordo com a meta de PTC de 0-10, 0-5 e 1- 2, as estimativas médias são 0,445, 0,65 e 0,833 mg.kg -1 h -1, respectivamente), sugerindo que um intervalo inferior e um máximo menor de resposta de PTC requerem maior quantidade de rocurônio para sua manutenção. A dose padrão de sugamadex (4 mg / kg), administrada ao final da cirurgia, leva mais tempo [2,85 (1,17) min] do que quando administrada após recuperação moderada do BNM [1,68 (0,47) min]. Conclusão: A infusão contínua para BNM profundo apresenta vantagens inerentes em termos de manutenção e estabilidade do relaxamento muscular. As abordagens de monitoramento e administração de rocurônio são fundamentais e intrinsecamente conectadas para fornecer uma manutenção estável e melhorada do BNM profundo.Bentham ScienceRepositório AbertoCouto, MafaldaCouto, J. GuilhermeNunes, Catarina S.Vide, SérgioAmorim, PedroMendes, Joaquim20212025-12-31T00:00:00Z2021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.2/11412engCouto M., J. G. Couto, C.S. Nunes, S. Vide, P. Amorim, and J. G. Mendes (2021) “Systematic Review on Rocuronium Continuous Infusion for Deep Neuromuscular Blockade.” Current Clinical Pharmacology, 16(1): 64-7210.2174/1574884714666191120144331info:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-16T15:39:07Zoai:repositorioaberto.uab.pt:10400.2/11412Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:50:49.794425Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Systematic review on Rocuronium continuous infusion for deep neuromuscular blockade
Revisão sistemática da infusão contínua de Rocurônio para bloqueio neuromuscular profundo
title Systematic review on Rocuronium continuous infusion for deep neuromuscular blockade
spellingShingle Systematic review on Rocuronium continuous infusion for deep neuromuscular blockade
Couto, Mafalda
Anesthesia
Neuromuscular blockade
Post-tetanic count
Continuous infusion
Deep NMB
Rocuronium
Anestesia
Bloqueio neuromuscular
Contagem pós-tetânica
Infusão contínua
BNM profundo
Rocurônio
title_short Systematic review on Rocuronium continuous infusion for deep neuromuscular blockade
title_full Systematic review on Rocuronium continuous infusion for deep neuromuscular blockade
title_fullStr Systematic review on Rocuronium continuous infusion for deep neuromuscular blockade
title_full_unstemmed Systematic review on Rocuronium continuous infusion for deep neuromuscular blockade
title_sort Systematic review on Rocuronium continuous infusion for deep neuromuscular blockade
author Couto, Mafalda
author_facet Couto, Mafalda
Couto, J. Guilherme
Nunes, Catarina S.
Vide, Sérgio
Amorim, Pedro
Mendes, Joaquim
author_role author
author2 Couto, J. Guilherme
Nunes, Catarina S.
Vide, Sérgio
Amorim, Pedro
Mendes, Joaquim
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Aberto
dc.contributor.author.fl_str_mv Couto, Mafalda
Couto, J. Guilherme
Nunes, Catarina S.
Vide, Sérgio
Amorim, Pedro
Mendes, Joaquim
dc.subject.por.fl_str_mv Anesthesia
Neuromuscular blockade
Post-tetanic count
Continuous infusion
Deep NMB
Rocuronium
Anestesia
Bloqueio neuromuscular
Contagem pós-tetânica
Infusão contínua
BNM profundo
Rocurônio
topic Anesthesia
Neuromuscular blockade
Post-tetanic count
Continuous infusion
Deep NMB
Rocuronium
Anestesia
Bloqueio neuromuscular
Contagem pós-tetânica
Infusão contínua
BNM profundo
Rocurônio
description Background: Rocuronium is a muscle relaxant with increased use due to its binding relation with the reversal agent sugammadex. The purpose of this review entails the investigation of its use for the maintenance of Deep Neuromuscular Block (NMB) via continuous infusion. Methods: Based on PRISMA systematic search guidelines, databases included PubMed, ISI Web of Science, Cochrane Library and Google Scholar. This comprehensive search addresses surgical patients under deep muscle relaxation via continuous rocuronium infusion. The main indicators were the rocuronium administration, NMB monitoring approaches and effects in order to maintain the deep level of relaxation, as well as reversal time after a standard dose of sugammadex. Results: Despite the variance in approaches found in the literature, findings show the overall maintenance of deep NMB requires approximately 0.758 mg.kg-1h-1 of rocuronium (according to the PTC target of 0-10, 0-5 and 1-2, mean estimates are 0.445, 0.65 and 0.833 mg.kg-1h-1 respectively), suggesting that a lower range and a smaller maximum of PTC response require higher amount of rocuronium for its maintenance. The standard dose of sugammadex (4 mg/kg), administered at the end of the surgery takes longer [2.85 (1.17) min] than when they are administered after moderate NMB recovery [1.68 (0.47) min]. Conclusion: Continuous infusion for deep NMB presents inherent advantages in terms of maintenance and stability of muscle relaxation. Monitoring and rocuronium administration approaches are fundamental and intrinsically connected to provide a stable and improved maintenance of deep NMB.
publishDate 2021
dc.date.none.fl_str_mv 2021
2021-01-01T00:00:00Z
2025-12-31T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.2/11412
url http://hdl.handle.net/10400.2/11412
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Couto M., J. G. Couto, C.S. Nunes, S. Vide, P. Amorim, and J. G. Mendes (2021) “Systematic Review on Rocuronium Continuous Infusion for Deep Neuromuscular Blockade.” Current Clinical Pharmacology, 16(1): 64-72
10.2174/1574884714666191120144331
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Bentham Science
publisher.none.fl_str_mv Bentham Science
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799135096681267200